Cargando…
Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways
BACKGROUND AND OBJECTIVE: N-terminal pro-B-type natriuretic peptide (NT-proBNP) and soluble interleukin 1 receptor-like 1 ST2 (sST2) are biomarkers used to grade heart failure with reduced ejection fraction (HFrEF) severity. Both are potential targets of HFrEF treatment, but the first is associated...
Autores principales: | Mapelli, Massimo, Mattavelli, Irene, Salvioni, Elisabetta, Bonomi, Alice, Capra, Nicolò, Palermo, Pietro, Banfi, Cristina, Paolillo, Stefania, Biondi, Maria Luisa, Agostoni, Piergiuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676328/ https://www.ncbi.nlm.nih.gov/pubmed/37702906 http://dx.doi.org/10.1007/s40268-023-00438-2 |
Ejemplares similares
-
Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure
por: Brioschi, Maura, et al.
Publicado: (2023) -
Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan
por: Mohebi, Reza, et al.
Publicado: (2023) -
Cardiac Reverse Remodelling by 2D and 3D Echocardiography in Heart Failure Patients Treated with Sacubitril/Valsartan
por: Mantegazza, Valentina, et al.
Publicado: (2021) -
Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration
por: Mapelli, Massimo, et al.
Publicado: (2023) -
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)